OC&C advises Alto and Arca Space Capital in private-label medical and cosmetics investment
Monday 13 May 2024 | NewsWe're pleased to congratulate Alto Partners S.G.R. S.p.A (Alto Partners) and Arca Fondi S.G.R. S.p.A. (Arca Fondi) on reaching an agreement for the acquisition of Eurosirel S.p.A. We advised Alto Capital and Arca Space Capital Buyside.
Eurosirel S.p.A is an Italian company, operating in the production and distribution of innovative private-label medical devices and cosmetics products for national and international clients including pharmacies, generalist/specialised retailers and pharmaceutical companies. Eurosirel S.p.A. researches, certifies and each year produces new products to offer their customers a range in constant development.
We wish Alto Partners, Arca Space Capital and Eurosirel every success in the next step of their journey.
OC&C and Private Equity
We’re a leading global strategy consultancy, with deep expertise in the healthcare and cosmetics sectors, working with both major global corporations and local champions. In private equity, we have commercially advised on more than 500 successful transactions over the last 5 years, encompassing sell-side and buy-side roles.
How we can help:
- We provide commercial due diligence and vendor due diligence for transactions.
- We assist investors with accelerating or improving their portfolio companies' performance.
- We help investors identify potential investment themes or assets to target.
For more details on our experience in this space, please contact:
Marco Costaguta, Partner
Simona Dossena, Partner